Hans-Peter Kiem mainly investigates Transplantation, Immunology, Stem cell, Haematopoiesis and Genetic enhancement. His Transplantation research incorporates elements of Total body irradiation and Immunosuppression. His biological study spans a wide range of topics, including Cytotoxic T cell, Cancer research and Cellular differentiation.
His study in Stem cell is interdisciplinary in nature, drawing from both Immune system and Virology. The various areas that Hans-Peter Kiem examines in his Haematopoiesis study include Progenitor cell, CD34, Bone marrow and Baboon. The concepts of his Genetic enhancement study are interwoven with issues in Leukemia, Pharmacology, In vivo and Cell biology.
His scientific interests lie mostly in Genetic enhancement, Stem cell, Haematopoiesis, Immunology and Transplantation. His Genetic enhancement research is multidisciplinary, incorporating perspectives in Virology, Viral vector, Hematopoietic stem cell and Severe combined immunodeficiency, In vivo. His work in Stem cell covers topics such as Cancer research which are related to areas like Chemotherapy and Immunotherapy.
His Haematopoiesis study integrates concerns from other disciplines, such as Progenitor cell, CD34, Molecular biology, Transduction and Bone marrow. His Transplantation research incorporates themes from Total body irradiation and Immunosuppression. His Internal medicine research integrates issues from Gastroenterology, Surgery and Oncology.
His primary areas of investigation include Cancer research, Progenitor cell, Haematopoiesis, Transplantation and Genetic enhancement. His work carried out in the field of Cancer research brings together such families of science as Leukemia, CD33, In vivo and Immunotherapy. Hans-Peter Kiem has included themes like CD34, Hematopoietic stem cell, Ex vivo and Immunology in his Progenitor cell study.
His study on Haematopoiesis is covered under Stem cell. His studies deal with areas such as T cell, Total body irradiation and CD90 as well as Transplantation. His Genetic enhancement research includes themes of Computational biology, Viral vector, Bioinformatics and Virology.
The scientist’s investigation covers issues in Haematopoiesis, Cancer research, Fludarabine, Internal medicine and Stem cell. As part of one scientific family, Hans-Peter Kiem deals mainly with the area of Haematopoiesis, narrowing it down to issues related to the Progenitor cell, and often Ex vivo, Transduction and Antibody. His Fludarabine study combines topics in areas such as Oncology and Immunotherapy.
He combines subjects such as Fetal hemoglobin, Hereditary persistence of fetal hemoglobin, Transfection, Humanized mouse and Transplantation with his study of Stem cell. Hans-Peter Kiem has researched Transplantation in several fields, including Molecular biology, HBG1 and Bone marrow. As a part of the same scientific family, he mostly works in the field of CD90, focusing on Hematopoietic stem cell transplantation and, on occasion, Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier.
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts
James J.H. Chong;Xiulan Yang;Creighton W. Don;Elina Minami.
Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg.
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Ingo G H Schmidt-Wolf;Robert S. Negrin;Hans Peter Kiem;Karl G. Blume.
Journal of Experimental Medicine (1991)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee.
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
Iman Fares;Jalila Chagraoui;Yves Gareau;Stéphane Gingras.
Improved Gene Transfer Into Baboon Marrow Repopulating Cells Using Recombinant Human Fibronectin Fragment CH-296 in Combination With Interleukin-6, Stem Cell Factor, FLT-3 Ligand, and Megakaryocyte Growth and Development Factor
Hans Peter Kiem;Hans Peter Kiem;Robert G. Andrews;Robert G. Andrews;Julia Morris;Julia Morris;Laura Peterson;Laura Peterson.
Survival of the fittest: in vivo selection and stem cell gene therapy.
Tobias Neff;Brian C. Beard;Hans Peter Kiem.
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano.
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
H. Joachim Deeg;Barry Storer;John T. Slattery;Claudio Anasetti.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: